Fibrin gels engineered with pro-angiogenic growth factors promote engraftment of pancreatic islets in extrahepatic sites in mice

Biotechnology and Bioengineering

Volumn 112, Issue 9, 2015, Pages 1916-1926

  Najjar, Mejdi ^a   Manzoli, Vita ^a,d   Abreu, Maria ^a   Villa, Chiara ^a,e,f   Martino, Mikaël M ^b   Molano, R Damaris ^a   Torrente, Yvan ^a,e,f   Pileggi, Antonello ^a,c   Inverardi, Luca ^a   Ricordi, Camillo ^a,c   Hubbell, Jeffrey A ^a,b,g   Tomei, Alice A ^a,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b EPFL   (Switzerland)

^c University of Miami College of Engineering   (United States)

^d POLITECNICO DI MILANO   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f MAGGIORE HOSPITAL   (Italy)

^g UNIVERSITY OF CHICAGO   (United States)

Author keywords

Angiogenesis; Hydrogels; Islet transplantation; Local release; PDGF BB; VEGF A

Indexed keywords

BINS; ENDOTHELIAL CELLS; ENZYME ACTIVITY; GRAFTING (CHEMICAL); HYDROGELS; MAMMALS; TISSUE;

ANGIOGENESIS; ISLET TRANSPLANTATION; LOCAL RELEASE; PDGF BB'S; VEGF-A;

GRAFTS;

ANGIOGENIC FACTOR; APROTININ; FIBRIN; PLATELET DERIVED GROWTH FACTOR BB; PRO ANGIOGENIC GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; HYDROGEL; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENGINEERING; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; ENGRAFTMENT; EPIDIDYMIS FAT; EX VIVO STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; GEL; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS TRANSPLANTATION; PROTEIN DEGRADATION; REVASCULARIZATION; SUBCUTANEOUS FAT; ANIMAL; C57BL MOUSE; CHEMISTRY; DEFICIENCY; DRUG EFFECTS; HUMAN; HYDROGEL; PANCREAS ISLET TRANSPLANTATION;

MUS;

ANIMALS; CELL PROLIFERATION; FIBRIN; HUMANS; HYDROGELS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-SIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84937739152     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.25589     Document Type: Article

References (57)

1. Ao Z, Matayoshi K, Lakey JR, Rajotte RV, Warnock GL. 1993. Survival and function of purified islets in the omental pouch site of outbred dogs. Transplantation 56(3):524-529.
2. Barkai U, Weir GC, Colton CK, Ludwig B, Bornstein SR, Brendel MD, Neufeld T, Bremer C, Leon A, Evron Y. 2012. Enhanced oxygen supply improves islet viability in a new bioartificial pancreas. Cell Transplant.
3. Barshes NR, Wyllie S, Goss JA. 2005. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: Implications for intrahepatic grafts. J Leukoc Biol 77(5):587-597.
4. Beattie GM, Montgomery AM, Lopez AD, Hao E, Perez B, Just ML, Lakey JR, Hart ME, Hayek A. 2002. A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes 51(12):3435-3439.
5. Berman DM, O'Neil JJ, Coffey LC, Chaffanjon PC, Kenyon NM, Ruiz P, Jr., Pileggi A, Ricordi C, Kenyon NS. 2009. Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold. Am J Transplant 9(1):91-104.
6. Brissova M, Shostak A, Shiota M, Wiebe PO, Poffenberger G, Kantz J, Chen Z, Carr C, Jerome WG, Chen J. 2006. Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 55(11):2974-2985.
7. Cantarelli E, Piemonti L. 2011. Alternative transplantation sites for pancreatic islet grafts. Curr Diab Rep 11(5):364-374.
8. Colton CK. 1995. Implantable biohybrid artificial organs. Cell Transplant 4(4):415-436.
9. Eming SA, Hubbell JA. 2011. Extracellular matrix in angiogenesis: Dynamic structures with translational potential. Exp Dermatol 20(7):605-613.
10. Gibly RF, Graham JG, Luo X, Lowe WL, Jr., Hering BJ, Shea LD. 2011. Advancing islet transplantation: From engraftment to the immune response. Diabetologia 54(10):2494-2505.
11. Gill RG, Bishop NH. 2012. Clinical islet transplantation: Where immunity and metabolism intersect?. Curr Opin Endocrinol Diabetes Obes 19(4):249-254.
12. Golocheikine A, Tiriveedhi V, Angaswamy N, Benshoff N, Sabarinathan R, Mohanakumar T. 2010. Cooperative signaling for angiogenesis and neovascularization by VEGF and HGF following islet transplantation. Transplantation 90(7):725-731.
13. Gu Y, Tabata Y, Kawakami Y, Balamurugan AN, Hori H, Nagata N, Satake A, Cui W, Qi M, Misawa Y. 2001. Development of a new method to induce angiogenesis at subcutaneous site of streptozotocin-induced diabetic rats for islet transplantation. Cell Transplant 10(4-5):453-457.
14. Gustavson SM, Rajotte RV, Hunkeler D, Lakey JR, Edgerton DS, Neal DW, Snead WL, Penaloza AR, Cherrington AD. 2005. Islet auto-transplantation into an omental or splenic site results in a normal beta cell but abnormal alpha cell response to mild non-insulin-induced hypoglycemia. Am J Transplant 5(10):2368-2377.
15. Hao X, Silva EA, Mansson-Broberg A, Grinnemo KH, Siddiqui AJ, Dellgren G, Wardell E, Brodin LA, Mooney DJ, Sylven C. 2007. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res 75(1):178-185.
16. Harlan DM, Kenyon NS, Korsgren O, Roep BO. 2009. Current advances and travails in islet transplantation. Diabetes 58(10):2175-2184.
17. Hussey AJ, Winardi M, Han XL, Thomas GP, Penington AJ, Morrison WA, Knight KR, Feeney SJ. 2009. Seeding of pancreatic islets into prevascularized tissue engineering chambers. Tissue Eng Part A 15(12):3823-3833.
18. Jacobs-Tulleneers-Thevissen D, Bartholomeus K, Suenens K, Vermeulen I, Ling Z, Hellemans KH, In't Veld P, Pipeleers-Marichal M, Pipeleers D. 2010. Human islet cell implants in a nude rat model of diabetes survive better in omentum than in liver with a positive influence of beta cell number and purity. Diabetologia 53(8):1690-1699.
19. Jalili RB, Moeen Rezakhanlou, Hosseini-Tabatabaei A, Ao Z, Warnock GL, Ghahary A. 2011. Fibroblast populated collagen matrix promotes islet survival and reduces the number of islets required for diabetes reversal. J Cell Physiol 226(7):1813-1819.
20. Jansson L, Carlsson PO. 2002. Graft vascular function after transplantation of pancreatic islets. Diabetologia 45(6):749-763.
21. Johnson PR, Jones KE. 2012. Pancreatic islet transplantation. Semin Pediatr Surg 21(3):272-280.
22. Juang JH, Bonner-Weir S, Ogawa Y, Vacanti JP, Weir GC. 1996. Outcome of subcutaneous islet transplantation improved by polymer device. Transplantation 61(11):1557-1561.
23. Juang JH, Hsu BR, Kuo CH. 2005. Islet transplantation at subcutaneous and intramuscular sites. Transplant Proc 37(8):3479-3481.
24. Kenneth Ward . 2008. A review of the foreign-body response to subcutaneously-implanted devices: The role of macrophages and cytokines in biofouling and fibrosis. J Diabetes Sci Technol 2(5):768-777.
25. Kim HI, Yu JE, Park CG, Kim SJ. 2010. Comparison of four pancreatic islet implantation sites. J Korean Med Sci 25(2):203-210.
26. Kim JS, Lim JH, Nam HY, Lim HJ, Shin JS, Shin JY, Ryu JH, Kim K, Kwon IC, Jin SM, et al. 2012. In situ application of hydrogel-type fibrin-islet composite optimized for rapid glycemic control by subcutaneous xenogeneic porcine islet transplantation. J Control Release 162(2):382-390.
27. Kin T, Korbutt GS, Rajotte RV. 2003. Survival and metabolic function of syngeneic rat islet grafts transplanted in the omental pouch. Am J Transplant 3(3):281-285.
28. Kriz J, Vilk G, Mazzuca DM, Toleikis PM, Foster PJ, White DJ. 2012. A novel technique for the transplantation of pancreatic islets within a vascularized device into the greater omentum to achieve insulin independence. Am J Surg 203(6):793-797.
29. Lai Y, Schneider D, Kidszun A, Hauck-Schmalenberger I, Breier G, Brandhorst D, Brandhorst H, Iken M, Brendel MD, Bretzel RG, et al. 2005. Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation 79(11):1530-1536.
30. MacGregor RR, Williams SJ, Tong PY, Kover K, Moore WV, Stehno-Bittel L. 2006. Small rat islets are superior to large islets in in vitro function and in transplantation outcomes. Am J Physiol Endocrinol Metab 290(5):E771-E779.
31. Martino MM, Hubbell JA. 2010. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J 24(12):4711-4721.
32. Martino MM, Mochizuki M, Rothenfluh DA, Rempel SA, Hubbell JA, Barker TH. 2009. Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability. Biomaterials 30(6):1089-1097.
33. Martino MM, Tortelli F, Mochizuki M, Traub S, Ben-David D, Kuhn GA, Muller R, Livne E, Eming SA, Hubbell JA. 2011. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci Transl Med 3(100):100ra89.
34. Marzorati S, Bocca N, Molano RD, Hogan AR, Doni M, Cobianchi L, Inverardi L, Ricordi C, Pileggi A. 2009. Effects of systemic immunosuppression on islet engraftment and function into a subcutaneous biocompatible device. Transplant Proc 41(1):352-353.
35. McQuilling JP, Arenas-Herrera J, Childers C, Pareta RA, Khanna O, Jiang B, Brey EM, Farney AC, Opara EC. 2011. New alginate microcapsule system for angiogenic protein delivery and immunoisolation of islets for transplantation in the rat omentum pouch. Transplant Proc 43(9):3262-3264.
36. Mineo D, Pileggi A, Alejandro R, Ricordi C. 2009. Point: Steady progress and current challenges in clinical islet transplantation. Diabetes Care 32(8):1563-1569.
37. Nillesen ST, Geutjes PJ, Wismans R, Schalkwijk J, Daamen WF, van Kuppevelt TH. 2006. Increased angiogenesis in acellular scaffolds by combined release of FGF2 and VEGF. J Control Release 116(2):e88-e90.
38. Nishimura R, Nishioka S, Fujisawa I, Shiku H, Shimada M, Sekiguchi S, Fujimori K, Ushiyama A, Matsue T, Ohuchi N, et al. 2013. Tacrolimus inhibits the revascularization of isolated pancreatic islets. PLoS One 8(4):e56799.
39. Ohmura Y, Tanemura M, Kawaguchi N, Machida T, Tanida T, Deguchi T, Wada H, Kobayashi S, Marubashi S, Eguchi H, et al. 2010. Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice. Transplantation 90(12):1366-1373.
40. Pedraza E, Brady AC, Fraker CA, Molano RD, Sukert S, Berman DM, Kenyon NS, Pileggi A, Ricordi C, Stabler CL. 2012. Macroporous three dimensional pdms scaffolds for extrahepatic islet transplantation. Cell Transplant.
41. Phelps EA, Headen DM, Taylor WR, Thule PM, Garcia AJ. 2013. Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes. Biomaterials 34(19):4602-4611.
42. Pileggi A, Molano RD, Ricordi C, Zahr E, Collins J, Valdes R, Inverardi L. 2006. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 81(9):1318-1324.
43. Plesner A, Verchere CB. 2011. Advances and challenges in islet transplantation: Islet procurement rates and lessons learned from suboptimal islet transplantation. J Transplant 2011:979527.
44. Rajab A. 2010. Islet transplantation: Alternative sites. Curr Diab Rep 10(5):332-337.
45. Rickels MR. 2012. Recovery of endocrine function after islet and pancreas transplantation. Curr Diab Rep 12(5):587-596.
46. Rivas-Carrillo JD, Navarro-Alvarez N, Soto-Gutierrez A, Okitsu T, Chen Y, Tabata Y, Misawa H, Noguchi H, Matsumoto S, Tanaka N, et al. 2006. Amelioration of diabetes in mice after single-donor islet transplantation using the controlled release of gelatinized FGF-2. Cell Transplant 15(10):939-944.
47. Salvay DM, Rives CB, Zhang X, Chen F, Kaufman DB, Lowe WL, Jr., Shea LD. 2008. Extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation. Transplantation 85(10):1456-1464.
48. Shapiro AM. 2011. Strategies toward single-donor islets of Langerhans transplantation. Curr Opin Organ Transplant 16(6):627-631.
49. Stendahl JC, Wang LJ, Chow LW, Kaufman DB, Stupp SI. 2008. Growth factor delivery from self-assembling nanofibers to facilitate islet transplantation. Transplantation 86(3):478-481.
50. Stokes RA, Cheng K, Deters N, Lau SM, Hawthorne WJ, O'Connell PJ, Stolp J, Grey S, Loudovaris T, Kay TW, et al. 2013. Hypoxia-inducible factor-1alpha (HIF-1alpha) potentiates beta-cell survival after islet transplantation of human and mouse islets. Cell Transplant 22(2):253-266.
51. Tavakoli A, Liong S. 2012. Pancreatic transplant in diabetes. Adv Exp Med Biol 771:420-437.
52. Uonaga T, Toyoda K, Okitsu T, Zhuang X, Yamane S, Uemoto S, Inagaki N. 2010. FGF-21 enhances islet engraftment in mouse syngeneic islet transplantation model. Islets 2(4):247-251.
53. van der Windt DJ, Echeverri GJ, Ijzermans JN, Cooper DK. 2008. The choice of anatomical site for islet transplantation. Cell Transplant 17(9):1005-1014.
54. Vasir B, Jonas JC, Steil GM, Hollister-Lock J, Hasenkamp W, Sharma A, Bonner-Weir S, Weir GC. 2001. Gene expression of VEGF and its receptors Flk-1/KDR and Flt-1 in cultured and transplanted rat islets. Transplantation 71(7):924-935.
55. Vernon RB, Preisinger A, Gooden MD, D'Amico LA, Yue BB, Bollyky PL, Kuhr CS, Hefty TR, Nepom GT, Gebe JA. 2012. Reversal of diabetes in mice with a bioengineered islet implant incorporating a type I collagen hydrogel and sustained release of vascular endothelial growth factor. Cell Transplant 21(10):2099-2110.
56. Wang W, Gu Y, Tabata Y, Miyamoto M, Hori H, Nagata N, Touma M, Balamurugan AN, Kawakami Y, Nozawa M, et al. 2002. Reversal of diabetes in mice by xenotransplantation of a bioartificial pancreas in a prevascularized subcutaneous site. Transplantation 73(1):122-129.
57. Zhang N, Richter A, Suriawinata J, Harbaran S, Altomonte J, Cong L, Zhang H, Song K, Meseck M, Bromberg J, et al. 2004. Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes 53(4):963-970.